Nyxoah Appoints Dr. Maurits S. Boon, MD as Chief Medical Officer Mont-Saint-Guibert, Belgium – April 11, 2024, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced the appointment of Dr.

Nyxoah任命医学博士Mauritts S.Boon博士为首席医疗官，比利时蒙特圣吉伯特-2024年4月11日，CET时间下午10:30/ET时间下午4:30-Nyxoah SA（Euronext Brussels/Nasdaq:NYXH）（“Nyxoah”或“公司”），一家专注于开发和商业化治疗阻塞性睡眠呼吸暂停（OSA）的创新解决方案的医疗技术公司，今天宣布任命Dr。

Maurits S. Boon, MD as Chief Medical Officer. Dr. Boon joins Nyxoah from the Thomas Jefferson University, where he will continue part time as a professor and Vice Chairman, Education. He is dual board-certified in otolaryngology – head and neck surgery, as well as sleep medicine. Dr. Boon is one of two sleep surgeons with Jefferson Health to pioneer the use of hypoglossal nerve stimulation therapy (HGNS) and is internationally recognized as one of the most experienced surgeons performing HGNS procedures.

医学博士毛里斯·布恩（MauritsS.Boon）担任首席医疗官。布恩博士从托马斯·杰斐逊大学（ThomasJefferson University）加入Nyxoah，在那里他将继续兼职教授和教育副主席。他拥有耳鼻喉科-头颈外科以及睡眠医学的双重认证。布恩博士是杰斐逊健康公司（Jefferson Health）率先使用舌下神经刺激疗法（HGNS）的两位睡眠外科医生之一，也是国际公认的执行HGNS手术的最有经验的外科医生之一。

He has lectured worldwide on obstructive sleep apnea, has numerous publications and is co-editor of the first book on HGNS. “As an academic physician who has dedicated my professional career to the care of patients with sleep disordered breathing, I was privileged to participate in the DREAM U.S. pivotal trial.

他曾在全球范围内就阻塞性睡眠呼吸暂停进行演讲，出版了许多出版物，并且是第一本关于HGNS的书的联合编辑。“作为一名学术医生，我将自己的职业生涯奉献给了睡眠呼吸障碍患者的护理，我有幸参加了DREAM美国关键试验。

I was initially impressed by the results I saw in my patients and then equally impressed by the data that were recently reported. As such, I am honored to have been offered a position to join Nyxoah at such an exciting time. Bilateral hypoglossal nerve stimulation with Genio has tremendous potential and I am thrilled to work with their talented team to make a meaningful impact on the lives of patients with obstructive sleep apnea,” commented Dr.

我最初对我在患者身上看到的结果印象深刻，然后对最近报道的数据印象深刻。因此，我很荣幸能在如此激动人心的时刻获得加入Nyxoah的职位。Genio双侧舌下神经刺激具有巨大潜力，我很高兴能与他们的天才团队合作，对阻塞性睡眠呼吸暂停患者的生活产生有意义的影响。

Boon. “I could not be more excited to have Dr. Boon join Nyxoah. He is one of the pioneers in hypoglossal nerve stimulation and his de.

布恩。“我对布恩博士加入Nyxoah感到无比兴奋。他是舌下神经刺激和他的de的先驱之一。

Attachment

附件

ENGLISH_Nyxoah Appoints Maurits Boon MD as Chief Medical Officer

ENGLISH\u Nyxoah任命Maurits Boon MD为首席医疗官